Biotechnology Value Fund L P

Holdings History for Avalo Therapeutics, Inc. - Class A Common Stock (AVTX)

Symbol: AVTX on Nasdaq
Investment type: Equity / Class A Common Stock
Latest Disclosed Ownership: 1.46M shares
Security Ownership: 9.99%

BVF PARTNERS L P/IL ownership in Avalo Therapeutics, Inc. Class A Common Stock (AVTX)

2025-11-14 - BVF PARTNERS L P/IL has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.46M shares of Avalo Therapeutics, Inc. Class A Common Stock (AVTX). This represents 9.99% percent ownership of the company. In their previous filing dated 2025-02-14, BIOTECHNOLOGY VALUE FUND L P had reported owning 1.04M shares, indicating an increase of 40.4% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
BVF PARTNERS L P/IL	9.99%		$18.5M	1.46M	+419,609	+40.4%	$12.71	13G/A	9/30/2025	14 Nov 2025 16:00:31
BVF PARTNERS L P/IL	9.99%		$6.02M	1.04M			$5.80	13G/A	12/31/2024	14 Feb 2025 16:02:30